Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin

Sofie Jørgensen, Steffen Leth, Maja Sommerfelt, Lars Østergaard, Martin Tolstrup, Ole S. Søgaard

Open source

DOI: 10.1097/qad.0000000000001904
Published: 2018-07-31
Container: AIDS
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qad.0000000000001904,
  title = {Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin},
  author = {Sofie Jørgensen and Steffen Leth and Maja Sommerfelt and Lars Østergaard and Martin Tolstrup and Ole S. Søgaard},
  year = {2018},
  journal = {AIDS},
  doi = {10.1097/qad.0000000000001904},
  url = {https://doi.org/10.1097/qad.0000000000001904}
}

RIS

TY  - JOUR
TI  - Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin
AU  - Sofie Jørgensen
AU  - Steffen Leth
AU  - Maja Sommerfelt
AU  - Lars Østergaard
AU  - Martin Tolstrup
AU  - Ole S. Søgaard
PY  - 2018
JO  - AIDS
DO  - 10.1097/qad.0000000000001904
UR  - https://doi.org/10.1097/qad.0000000000001904
ER  -

APA

Jørgensen, S., Leth, S., Sommerfelt, M., Østergaard, L., Tolstrup, M., & Søgaard, O. S. (2018). Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin. AIDS. https://doi.org/10.1097/qad.0000000000001904

Source records

crossref · retrieved 2026-09-26T09:04:01.892Z